Role of capsular sialic acid in virulence and resistance to phagocytosis of Streptococcus suis capsular type 2

FEMS Immunology and Medical Microbiology

Volumn 14, Issue 4, 1996, Pages 195-203

  Charland, Nathalie ^a   Kobisch, Marylène ^b   Martineau Doizé, Béatrice ^a   Jacques, Mario ^a   Gottschalk, Marcelo ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Healthy Pigs Production and Experimentation Section   (France)

Author keywords

Capsule; Phagocytosis; Sialic acid; Streptococcus suis; Virulence

Indexed keywords

LECTIN; SIALIC ACID;

ANIMAL CELL; ARTICLE; COMPLEMENT ACTIVATION; HOST RESISTANCE; MONOCYTE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; STREPTOCOCCUS; SWINE; VIRULENCE;

EID: 0030199551     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/0928-8244(96)00030-2     Document Type: Article

References (36)

1. [1] Higgins, R., Gottschalk, M., Beaudoin, M. and Rawluk, S.A. (1992) Distribution of Streptococcus suis capsular types in Québec and western Canada. Can. Vet. J. 33, 27-30.
2. [2] Arends, J.P. and Zanen, H. (1988) Meningitis caused by Streptococcus suis in humans. Rev. Infect. Dis. 10, 131-137.
3. [3] Trottier, S., Higgins, R., Brochu, G. and Gottschalk, M. (1991) A case of human endocarditis due to Streptococcus suis in North America. Rev. Infect. Dis. 13, 1251-1252.
4. [4] Quessy, S., Dubreuil, D., Caya, M. and Higgins, R. (1995) Discrimination of virulent and avirulent Streptococcus suis capsular type 2 isolates from different geographical origins. Infect. Immun. 63, 1975-1979.
5. [5] Vecht, U., Arends, J.P., Van der Molen, E.J. and van Leenoped, L.A.M.G. (1989) Differences in virulence between two strains of Streptococcus suis type II after experimentally induced infection of newborn germ-free pigs. Am. J. Vet. Res. 50, 1037-1043.
6. [6] Williams, A.E. (1990) Relationship between intracellular survival in macrophages and pathogenicity of Streptococcus suis type 2 isolates. Microb. Pathogen. 8, 189-196.
7. [7] Gottschalk, M., Lacouture, S. and Dubreuil, J.D. (1995) Characterization of Streptococcus suis capsular type 2 haemolysin. Microbiology 141, 189-195.
8. [8] Jacques, M., Gottschalk, M., Foiry, B. and Higgins, R. (1990) Ultrastructural study of surface components of Streptococcus suis. J. Bacteriol. 172, 2833-2838.
9. [9] Vecht, U., Wisselink, H.J., Jellema, M.L. and Smith, H.E. (1991) Identification of two proteins associated with virulence of Streptococcus suis type 2. Infect. Immun. 59, 3156-3162.
10. [10] Domenico, P., Salo, R.J., Cross, A.S. and Cunha, B.A. (1994) Polysaccharide capsule-mediated resistance to opsonophagocytosis in Klebsiella pneumoniae. Infect. Immun. 62, 4495-4499.
11. [11] Yeung, M.K. and Mattingly, S.J. (1984) Biosynthetic capacity of type-specific antigen synthesis determines the virulence of serotype III strains of group B streptococci. Infect. Immun. 44, 217-221.
12. [12] Elliot, S.D. and Tai, J. (1978) The type-specific polysaccharides of Streptococcus suis. J. Exp. Med. 148, 1699-1704.
13. [13] Charland, N., Kellens, J.T.C., Caya, F. and Gottschalk, M. (1995) Agglutination of Streptococcus suis by sialic acid-binding lectins. J. Clin. Microbiol. 33, 2220-2221.
14. [14] Kazatchkine, M.D., Fearon, D.T. and Austen, K.F. (1979) Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and beta 1 H for cell-bound C3b. J. Immunol. 122, 75-81.
15. [15] Edwards, M.S., Kasper, D.L., Jennings, H.J., Baker, C.J. and Nicholson-Weller, A. (1982) Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. J. Immunol. 128, 1278-1283.
16. [16] Wessels, M.R., Rubens, C.E., Benedi, V.-J. and Kasper, D.L. (1989) Definition of a bacterial virulence factor: Sialylation of the group B streptococcal capsule. Proc. Natl. Acad. Sci. USA 86, 8983-8987.
17. [17] Smith, H. (1993) Gonococci in vivo: Host CMP-NANA. sialylated lipopolysaccharide and serum resistance. Can. J. Infect. Dis. 4, 31-37.
18. [18] Fine, D.P. (1975) Pneumococcal type-associated variability in alternate complement pathway activation. Infect. Immun. 12, 772-778.
19. [19] Brazeau, C., Gottschalk, M., Vincelette, S. and Martineau-Doizé, B. (1996) In vitro phagocytosis and survival of Streptococcus suis capsular type 2 inside murine macrophages. Microbiology, in press.
20. [20] Gottschalk, M., Higgins, R., Jacques, M. and Dubreuil, D. (1992) Production and characterization of two Streptococcus suis capsular type 2 mutants. Vet. Microbiol. 30, 59-71.
21. [21] Warren, L. (1963) Thiobarbituric acid assay for sialic acids. Methods Enzymol. 6, 463-464.
22. [22] Shigeoka, A.O., Rote, N.S., Santos, J.I. and Hill, H.R. (1983) Assessment of the virulence factors of group B streptococci: Correlation with sialic acid content. J. Infect. Dis. 147, 857-863.
23. [23] Day, S.E.J., Vasli, K.K., Russel, R.J. and Arbuthnott, J.P. (1980) A simple method of the study in vivo of bacterial growth and accompanying host response. J. Infect. 2, 39-51.
24. [24] Dom, P., Haesebrouck, F., Kamp, E.M. and Smits, M.A. (1992) Influence of Actinobacillus pleuropneumoniae serotype 2 and its cytolysins on porcine neutrophil chemiluminescence. Infect. Immun. 60, 4328-4334.
25. [25] Weiss, D.J., Kraemer, R. and Schmit, K. (1989) Isolation of granulocytes and mononuclear cells from the blood of dogs, cats, horses and cattle. Vet. Clin. Pathol. 18, 33-36.
26. [26] Goldner, M., Farkas-Himsley, H., Kormendy, A. and Skinner, M. (1983) Bacterial phagocytosis monitored by fluorescence and extracellular quenching: ingestion and intracellular killing. Lab. Med. 14, 291-294.
27. [27] Beaudoin, M., Higgins, R., Harel, J. and Gottschalk, M. (1992) Studies on a murine model for evaluation of virulence of Streptococcus suis capsular type 2 isolates. FEMS Microbiol. Lett. 78, 111-116.
28. [28] Glantz, S.A. (1987) Primer of Biostatistics, 2nd Edition, pp. 65-68. McGraw-Hill, Inc., NY.
29. [29] Nagano, Y., Nagano, N., Takahashi, S., Suzuki, A. and Okuwaki, Y. (1989) Sialic acid levels and lag time growth in chemically defined medium containing 200 mM phosphate among strains of various serotypes of Streptococcus agalactiae. J. Clin. Microhiol. 27, 2148-2151.
30. [30] Rittenberg, S.C., Penn, C.W., Parsons, N.J., Veale, D.R. and Smith, H. (1977) Phenotypic changes in the resistance of Neisseria gonorrhoeae to killing by normal human serum. J. Gen. Microbiol. 103, 69-75.
31. [31] Platt, M.W., Correa, N. Jr. and Mold, C. (1994) Growth of group B streptococci in human serum leads to increased cell surface sialic acid and decreased activation of the alternative complement pathway. Can. J. Microbiol. 40, 99-105.
32. [32] Kurl, D.N., Haataja, S. and Finne, J. (1989) Hemagglutination activities of group B, C, D, and G streptococci: demonstration of novel sugar-specific cell-binding activities in Streptococcus suis. Infect. Immun. 57, 384-389.
33. [33] Quessy, S., Dubreuil, J.D., Jacques, M., Malouin, F. and Higgins, R. (1994) Increase of capsular material thickness following in vivo growth of virulent Streptococcus suis serotype 2 strains. FEMS Microbiol. Lett. 115, 19-26.
34. [34] Clifton-Hadley, F.A., Alexander, T. and Enright, M. (1986) The epidemiology, diagnosis, treatment, and control of Streptococcus suis type 2 infection. Proc. Ann. Meet. Am. Assoc. Swine Pract. 471-491.
35. [35] Williams, A.E. and Blakemore, W.F. (1990) Pathogenesis of meningitis caused by Streptococcus suis type 2. J. Infect. Dis. 162, 474-481.
36. [36] Del Campo Sepulveda, E., Altman, E., Kobisch, M. and Gottschalk, M. (1996) Detection of serotype-specific antibodies against Streptococcus suis capsular type 2 using an indirect ELISA. Vet. Microbiol. in press.